Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells

Life Sciences

Volumn 62, Issue 2, 1997, Pages 151-163

  Chat, Mireille ^a   Bayol Denizot, Claire ^a   Suleman, Grace ^a   Roux, Françoise ^b   Minn, Alain ^a  

^a CNRS   (France)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

Blood brain barrier; Cerebral endothelial cells; Drug metabolizing enzymes; Superoxide radical

Indexed keywords

ANTHRAQUINONE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DIQUAT; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; MENADIONE; NITROFURAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL TYPE; CONTROLLED STUDY; DRUG METABOLISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; IMMUNOBLOTTING; MALE; NONHUMAN; RAT;

EID: 0031555354     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)01061-8     Document Type: Article

References (44)

1. ABBOTT N.J., HUGHES C.C.W., REVEST P.A., GREENWOOD J. J. Cell Sci. 103:1992;23-37.
2. JOÓ F. J. Neurochem. 58:1992;1-17.
3. S.I. HARIK and R.N. KALARIA, Cerebrovascular Diseases, Ginsberg M.D. and W.D. Dietrich (Eds) Raven Press, New York, 407-410 (1989).
4. BRADBURY M.W.B. Exp. Physiol. 78:1993;453-472.
5. Van GELDER N.M.A. Prog. Brain Res. 29:1968;259-268.
6. De FEUDIS F. Drugs Today. 24:1988;665-678.
7. GHERSI-EGEA J.F., MINN A., SIEST G. Life Sci. 42:1988;2515-2523.
8. MINN A., GHERSI-EGEA J.F., PERRIN R., LEININGER B., SIEST G. Brain Res. Rev. 16:1991;65-82.
9. LAGRANGE P., LIVERTOUX M.H., GRASSIOT M.C., MINN A. Free Rad. Biol. Med. 17:1994;355-359.
10. LEININGER B., GHERSI-EGEA J.F., SIEST G., MINN A. J. Neurochem. 56:1991;1163-1168.
11. JETTÉ L., MURPHY G.F., LECLERC J.M., BÉLIVEAU R. Biochem. Pharmacol. 50:1995;1701-1709.
12. DRION N., LEMAIRE M., LEFAUCONNIER J.M., SCHERRMANN J.M. J. Neurochem. 67:1996;1688-1693.
13. ROUX F., DURIEU-TRAUTMANN O., CHAVEROT N., CLAIRE M., MAILLY P., BOURRE J.M., STROSBERG A.D., COURAUD P.O. J. Cell Physiol. 159:1994;101-113.
14. BURCHELL B., BRIERLEY C.H., RANCE D. Life Sci. 57:1995;1819-1831.
15. A. MINN, D. GRADINARU, G.F. SULEMAN, M. CHAT, C. BAYOL-DENIZOT and P. LAGRANGE, Drug Transport to the Brain: New Experimental Strategies", W. Sutanto and A.G. de Boer (Eds) 37-47 (1997).
16. LOWRY O.H., ROSENBROUGH N.J., FARR A.L., RANDALL R.J. J. Biol. Chem. 193:1951;265-275.
17. H.W. STROBEL and J.D. DIGNAM, Methods in Enzymology, S.E. Fleischer and L. Packer (Eds), Vol. 52, 89-93. Academic Press, London (1978).
18. PERRIN R., MINN A., GHERSI-EGEA J.F., GRASSIOT M.C., SIEST G. Biochem. Pharmac. 40:1990;2145-2151.
19. LAEMMLI U.K. Nature. 227:1970;680-685.
20. BURNETTE W.N. Anal. Biochem. 112:1981;195-203.
21. SOUHAILI-EL AMRI H., FARGETTON X., BENOIT E., TOTIS M., BATT A.M. Toxicol. Appl. Pharmacol. 92:1988;141-149.
22. GHERSI-EGEA J.F., MINN A., DAVAL J.L., JAYYOZI Z., ARNOULD V., SOUHAILI-EI AMRI H., SIEST G. Neurochem. Res. 14:1989;883-888.
23. COUGHTRIE M.W.H., BURCHELL B., LEAKEY J.E.A., HUME R. Mol. Pharmacol. 34:1988;729-735.
24. DAVAL J.L., GHERSI-EGEA J.F., OILLET J., KOZIEL V. J. Cereb. Blood Flow Met. 15:1995;71-77.
25. SULEMAN F.G., GHERSI-EGEA J.F., LEININGER-MULLER B., MINN A. Neurosci. Lett. 161:1993;219-222.
26. JAYYOZI Z., TOTIS M., SOUHAILI H., GOULON-GINET C., LIVERTOUX M.H., BATT A.M., SIEST G. Biochem. Pharmacol. 36:1987;2481-2487.
27. GHERSI-EGEA J.F., LIVERTOUX M.H., MINN A., PERRIN R., SIEST G. Toxicol. Appl. Pharmacol. 110:1991;107-117.
28. LIVERTOUX M.H., LAGRANGE P., MINN A. Brain Res. 725:1996;207-216.
29. ABE K., SAITO H. Jpn. J. Pharmacol. 72:1996;299-306.
30. A.L. BETZ, The blood-Brain Barrier, W.M. Pardridge (Ed), 303-321 Raven Press, New York (1993).
31. DeBAULT L.E., CANCILLA P.A. Science. 207:1980;653-655.
32. MAXWELL K., BERLINER J.A., CANCILLA P.A. Brain Res. 410:1987;309-314.
33. DEHOUCK M.P., MÉRESSE S., DELORME P., FRUCHART J.C., CECCHELLI R. J. Neurochem. 54:1990;1798-1801.
34. EI HAFNY B., BOURRE J.M., ROUX F. J. Cell. Physiol. 167:1996;451-460.
35. GHERSI-EGEA J.F., LEININGER-MULLER B., SULEMAN G., SIEST G., MINN A. J. Neurochem. 62:1994;1089-1096.
36. JAHEDE U., GOTO T., De BOER A.G., BREIMER D.D. Eur. J. Pharmac. Sci. 1:1993;49-55.
37. ROSEN G.M., FREEMAN B.A. Proc. Natl. Acad. Sci. USA. 81:1984;7269-7273.
38. BANDY B., MOON J., DAVISON A.L. Free Rad. Biol. Med. 9:1990;143-148.
39. BUTLER J., HOEY B.M. J. Free Rad. Biol. Med. 2:1986;77-81.
40. NAYLOR J.L., WIDDOWSON P.S., SIMPSON M.G., FARNWORTH M., ELLIS M.K., LOCK E.A. Human Exp. Toxicol. 14:1995;587-594.
41. LIOU H.H., CHEN R.C., TSAI Y.F., CHEN W.P., CHANG Y.C., TSAI M.C. Toxicol. Appl. Pharmacol. 137:1996;34-41.
42. TAYARANI Y., CLOËZ I., CLÉMENT M., BOURRE J.M. J. Neurochem. 53:1989;817-824.
43. IMAIZUMI S., KONDO T., DELI M.A., GOBBEL G., JOÓ F., EPSTEIN C.J., YOSHIMOTO T., CHAN P.K. Neurochem. Int. 29:1996;205-211.
44. MERTSCH K., GRUNE T., SIEMS W.G., LADHOFF A., SAUPE N., BLASIG I.E. Cell. Mol. Biol. 41:1995;243-253.